The Journal of npj Precision Oncology (npj Precision Oncology) Official Published
On March 23rd. This journal was founded by China-US (Henan) Hormel Cancer Institute, Hormel Institute (American) and Nature. The journal is committed to publishing advanced scientific research in all fields of tumor precision medicine, basic research designing, application transforming and clinical study.
Dr. Ann Bode, the vice-president of Hormel Institute (American) and the Head of cancer biomarkers developing and drug resistance research group. The first publication of this journal reported the papers of Webster K. Cavenee and Dr. Ann Bode，and many kinds of high level articles in the field were also been published.
npj Precision Oncology invites many academicians and experts and scholars to participate in editors, leading readers to deeply reading, surpassing the traditional research boundaries, pushing scientific research into a wider crowd, and creating a high-end academic exchange platform for cancer research. This journal is the first publication in China which cooperates with Nature Publishing Group in the field of cancer medicine. It provides abundant research resources for cancer research in China, enhances the innovative and improves research advantages of cancer research. At the same time, it will provide the opportunity to show the results of our cancer research in high level academic journals, attract more international cooperation projects, and make new breakthroughs in cancer research and prevention.